CN Patent

CN107638403B — 一种硬胶囊制剂

Assigned to Jiangsu Weikaier Pharmaceutical Technology Co ltd · Expires 2020-05-05 · 6y expired

What this patent protects

本发明涉及一种鲁比前列酮硬胶囊制剂及其制备方法，所述制剂包括明胶胶囊囊壳及含有鲁比前列酮的颗粒、润滑剂。该制剂药物含量均匀，稳定性优良，药物具备体外快速溶出特效，操作简便，尤其适用于固体制剂车间的工业化生产。

USPTO Abstract

本发明涉及一种鲁比前列酮硬胶囊制剂及其制备方法，所述制剂包括明胶胶囊囊壳及含有鲁比前列酮的颗粒、润滑剂。该制剂药物含量均匀，稳定性优良，药物具备体外快速溶出特效，操作简便，尤其适用于固体制剂车间的工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN107638403B
Jurisdiction
CN
Classification
—
Expires
2020-05-05
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Weikaier Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.